Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma

Gunjan L. Shah, Craig Moskowitz

Research output: Contribution to journalReview article

Abstract

For initial staging and at end of treatment to document remission status, PET is the standard imaging modality. Interim scanning remains investigational. Surveillance PET is not beneficial in the majority of patients. PET has also been used to predict outcome in the pre-autologous transplant setting. PET in the pre-allogeneic setting has a less established benefit. There is limited data on its use after transplant.

Original languageEnglish (US)
Pages (from-to)1215-1228
Number of pages14
JournalHematology/Oncology Clinics of North America
Volume30
Issue number6
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Autografts
Positron-Emission Tomography
Transplants
Therapeutics

Keywords

  • Diffuse large B-cell lymphoma
  • Positron emission tomography
  • Transplant

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma. / Shah, Gunjan L.; Moskowitz, Craig.

In: Hematology/Oncology Clinics of North America, Vol. 30, No. 6, 01.12.2016, p. 1215-1228.

Research output: Contribution to journalReview article

@article{957f96be8f0149b5acdc44141c71257b,
title = "Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma",
abstract = "For initial staging and at end of treatment to document remission status, PET is the standard imaging modality. Interim scanning remains investigational. Surveillance PET is not beneficial in the majority of patients. PET has also been used to predict outcome in the pre-autologous transplant setting. PET in the pre-allogeneic setting has a less established benefit. There is limited data on its use after transplant.",
keywords = "Diffuse large B-cell lymphoma, Positron emission tomography, Transplant",
author = "Shah, {Gunjan L.} and Craig Moskowitz",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.hoc.2016.07.003",
language = "English (US)",
volume = "30",
pages = "1215--1228",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma

AU - Shah, Gunjan L.

AU - Moskowitz, Craig

PY - 2016/12/1

Y1 - 2016/12/1

N2 - For initial staging and at end of treatment to document remission status, PET is the standard imaging modality. Interim scanning remains investigational. Surveillance PET is not beneficial in the majority of patients. PET has also been used to predict outcome in the pre-autologous transplant setting. PET in the pre-allogeneic setting has a less established benefit. There is limited data on its use after transplant.

AB - For initial staging and at end of treatment to document remission status, PET is the standard imaging modality. Interim scanning remains investigational. Surveillance PET is not beneficial in the majority of patients. PET has also been used to predict outcome in the pre-autologous transplant setting. PET in the pre-allogeneic setting has a less established benefit. There is limited data on its use after transplant.

KW - Diffuse large B-cell lymphoma

KW - Positron emission tomography

KW - Transplant

UR - http://www.scopus.com/inward/record.url?scp=84997496918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997496918&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2016.07.003

DO - 10.1016/j.hoc.2016.07.003

M3 - Review article

C2 - 27888876

AN - SCOPUS:84997496918

VL - 30

SP - 1215

EP - 1228

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 6

ER -